The jury for the Ecoantibio 2024 Research Prize has now been appointed.

The jury for the Ecoantibio 2024 Research Prize has now been appointed:

• Sébastien Geollot, VIRBAC
• Frédéric Lemarchand, ZOETIS
• Marc Henninger, ELANCO
• Marie-Anne Barthélémy, SIMV
• Claire Chauvin, ANSES
• François Schelcher, ENVT
• Jean-Yves Madec, ANSES

The French Association for Veterinary Medicine and Diagnostics Industry (SIMV) has launched the 2024 Edition call for scientific publications to compete for the special Ecoantibio research prize.

We remind you that publications must be submitted by April 30, 2024.

This Prize recognizes a scientific publication from 2023.

It aims to distinguish research work published by a student or researcher meeting the following criteria:

• Works highlighting the positive impact of vaccination
• Works contributing to the development of therapeutic solutions to combat the risk of antimicrobial resistance emergence.

Only projects with potential for exploitation by the veterinary pharmaceutical industry are eligible.

Application procedures for 2024:

Publications from 2023 can be sent to the RFSA secretariat from now until April 30, 2024, at the following address: secretariat@rfsa.net

For Muriel Vayssier-Taussat, INRAE:

“This is an initiative followed by INRAE researchers, which truly embodies the One Health approach of bringing together knowledge across all sectors.”

The 2024 Edition rules are available.

As a reminder, the publication recognized by the Ecoantibio 2023 research prize was:

“Enhancing Colistin Activity against Colistin-Resistant Escherichia coli through Combination with Alginate Nanoparticles and Small Molecules”. Pharmaceuticals. NOURA HAZIME, YANATH BELGUESMIA, ISABELLE KEMPF, ALEXANDRE BARRAS, DJAMEL DRIDER, RABAH BOUKHERROUB.

See the SIMV press release via the link.

Please share this information to allow us to have a wide selection of publications!